Literature DB >> 8668504

Visuomotor performance in children with infantile nephropathic cystinosis.

K M Scarvie1, A O Ballantyne, D A Trauner.   

Abstract

Infantile nephropathic cystinosis is a genetic metabolic disorder in which the amino acid cystine accumulates in various organs, including the kidney, cornea, thyroid, and brain. Despite normal intellect, individuals with cystinosis may have specific impairments in the processing of visual information. To examine further the specific types of deficits in visual processing found in individuals with cystinosis, we administered the Development Test of Visual-motor Integration to 26 children with cystinosis (4 to 16 yr. old) and 26 matched controls. The cystinosis group achieved a significantly lower standard score, raw score, and mean ceiling than did the control group. Qualitative analyses showed that in the cystinosis group, size within errors and rotation errors were more prevalent than in the control group. Correlational analyses showed that with advancing age, the cystinosis subjects tended to fall further behind their chronological age. Our data, together with the findings of previous studies, suggest that the visuospatial difficulties in children with cystinosis may be due to inadequate perception or processing of visually presented information. Furthermore, the increasing discrepancy with age may reflect a progressive cognitive impairment, possibly as a result of cystine accumulation in the brain over time.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668504     DOI: 10.2466/pms.1996.82.1.67

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  12 in total

1.  Visual and verbal learning in a genetic metabolic disorder.

Authors:  Amy M Spilkin; Angela O Ballantyne; Doris A Trauner
Journal:  Neuropsychologia       Date:  2009-03-09       Impact factor: 3.139

Review 2.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

3.  Cognition in nephropathic cystinosis: pattern of expression in heterozygous carriers.

Authors:  Stephen Niemiec; Angela Ballantyne; Doris A Trauner
Journal:  Am J Med Genet A       Date:  2012-07-11       Impact factor: 2.802

4.  Executive function in nephropathic cystinosis.

Authors:  Angela O Ballantyne; Amy M Spilkin; Doris A Trauner
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600

5.  Neurological impairment in nephropathic cystinosis: motor coordination deficits.

Authors:  Doris A Trauner; Jennifer Williams; Angela O Ballantyne; Amy M Spilkin; Jennifer Crowhurst; John Hesselink
Journal:  Pediatr Nephrol       Date:  2010-07-22       Impact factor: 3.714

6.  Developmental changes in cerebral white matter microstructure in a disorder of lysosomal storage.

Authors:  Sunita Bava; Rebecca J Theilmann; Miriam Sach; Susanne J May; Lawrence R Frank; John R Hesselink; Duc Vu; Doris A Trauner
Journal:  Cortex       Date:  2009-04-05       Impact factor: 4.027

7.  Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.

Authors:  Jennifer A Hollywood; Aneta Przepiorski; Randall F D'Souza; Sreevalsan Sreebhavan; Ernst J Wolvetang; Patrick T Harrison; Alan J Davidson; Teresa M Holm
Journal:  J Am Soc Nephrol       Date:  2020-03-20       Impact factor: 10.121

8.  Specific cognitive deficits in young children with cystinosis: evidence for an early effect of the cystinosin gene on neural function.

Authors:  Doris A Trauner; Amy M Spilkin; Jennifer Williams; Lynne Babchuck
Journal:  J Pediatr       Date:  2007-06-22       Impact factor: 4.406

9.  Effect of age at treatment on cognitive performance in patients with cystinosis.

Authors:  Lisa Viltz; Doris A Trauner
Journal:  J Pediatr       Date:  2013-02-22       Impact factor: 4.406

10.  Germline DNA copy number variation in individuals with Argyrophilic grain disease reveals CTNS as a plausible candidate gene.

Authors:  Darine Villela; Lilian Kimura; David Schlesinger; Amanda Gonçalves; Peter L Pearson; Claudia K Suemoto; Carlos Pasqualucci; Ana Cristina Krepischi; Lea T Grinberg; Carla Rosenberg
Journal:  Genet Mol Biol       Date:  2013-11-08       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.